MedPath

University of Oxford

University of Oxford logo
πŸ‡¬πŸ‡§United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

T-Cell Turnover Following Vaccination With MVA85A

Phase 1
Completed
Conditions
Tuberculosis
First Posted Date
2007-10-24
Last Posted Date
2010-01-18
Lead Sponsor
University of Oxford
Target Recruit Count
12
Registration Number
NCT00548444
Locations
πŸ‡¬πŸ‡§

University of Oxford, Oxford, Oxfordshire, United Kingdom

Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia

Not Applicable
Completed
Conditions
Falciparum Malaria
Interventions
First Posted Date
2007-06-28
Last Posted Date
2018-05-04
Lead Sponsor
University of Oxford
Target Recruit Count
40
Registration Number
NCT00493363
Locations
πŸ‡°πŸ‡­

Pailin Referal Hospital, Pailin, Cambodia

Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines

Phase 1
Completed
Conditions
TB
First Posted Date
2007-05-31
Last Posted Date
2010-02-09
Lead Sponsor
University of Oxford
Target Recruit Count
214
Registration Number
NCT00480454
Locations
πŸ‡¬πŸ‡²

MRC, Banjul, Gambia

A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers

Phase 1
Completed
Conditions
TB
First Posted Date
2007-05-31
Last Posted Date
2007-05-31
Lead Sponsor
University of Oxford
Target Recruit Count
11
Registration Number
NCT00480688
Locations
πŸ‡¬πŸ‡§

University of Oxford, CCVTM, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers

Not Applicable
Completed
Conditions
TB
First Posted Date
2007-05-31
Last Posted Date
2007-05-31
Lead Sponsor
University of Oxford
Target Recruit Count
10
Registration Number
NCT00480714
Locations
πŸ‡¬πŸ‡§

University of Oxford, CCVTM, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Phase 1
Completed
Conditions
HIV Infections
TB
First Posted Date
2007-05-31
Last Posted Date
2011-03-28
Lead Sponsor
University of Oxford
Target Recruit Count
48
Registration Number
NCT00480558
Locations
πŸ‡ΏπŸ‡¦

University Cape Town, Cape Town, South Africa

A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG

Phase 1
Completed
Conditions
Tuberculosis
First Posted Date
2007-04-25
Last Posted Date
2008-04-04
Lead Sponsor
University of Oxford
Target Recruit Count
24
Registration Number
NCT00465465
Locations
πŸ‡¬πŸ‡§

University of Oxford, CCVTM, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE

Phase 3
Completed
Conditions
Cardiovascular Disease
Peripheral Arterial Disease
Diabetes Mellitus
Coronary Heart Disease
Interventions
First Posted Date
2007-04-18
Last Posted Date
2014-02-28
Lead Sponsor
University of Oxford
Target Recruit Count
25673
Registration Number
NCT00461630
Locations
πŸ‡¬πŸ‡§

Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom

The Effectiveness of Supported Employment for People With Severe Mental Illness: an RCT in Six European Countries

Not Applicable
Completed
Conditions
Psychosis
First Posted Date
2007-04-18
Last Posted Date
2007-04-18
Lead Sponsor
University of Oxford
Target Recruit Count
300
Registration Number
NCT00461318
Locations
πŸ‡¬πŸ‡§

Division of mental health, St Georges medical school, university of london, London, United Kingdom

Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town

Phase 1
Completed
Conditions
Tuberculosis
First Posted Date
2007-04-16
Last Posted Date
2008-08-07
Lead Sponsor
University of Oxford
Target Recruit Count
36
Registration Number
NCT00460590
Locations
πŸ‡ΏπŸ‡¦

University Cape Town, Cape Town, South Africa

Β© Copyright 2025. All Rights Reserved by MedPath